Healthcare Realty Trust Inc HR
998 filings, 3 in the last 30 days
SEC filing indexWhat the 8-Ks said
2 events in the last 3 years: the officer, auditor, restatement, cyber, restructuring, listing, impairment and debt items. One line each, the filing's own words.
- Feb 23, 2026 Auditor changeChanged the accounting firm that audits it “Changes in Registrant's Certifying Accountant. On February 19, 2026, the Audit Committee of the Board of Directors (the “Audit Committee”) of Healthcare Realty Trust Incorporated (the “Company”), elected to replace BDO USA, P.C. ("BDO") with Deloitte & Touche LLP (“Deloitte”) as the Company’s independent registered public accounting firm, effective as of February 19, 2026. BDO’s reports on the…” 8-K item 4.01 · all documents
- Jan 7, 2026 CEO, CFO, COO or CAOCFO change “The Board of Directors of Healthcare Realty Trust Incorporated (the “Company”) has appointed Daniel Gabbay to serve as the Company’s Executive Vice President and Chief Financial Officer effective January 12, 2026.” 8-K item 5.02 · all documents
From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.
Late filings, 8-K notices and going concern
None found in the last 2 years
-
Late filing notices (NT 10-K, NT 10-Q)No notice in the last 2 years.
-
8-K notices: listing, impairment, debt triggerNo item 3.01, 2.06 or 2.04 in the last 2 years.
-
Going-concern language in the 10-KNo statement of substantial doubt in the latest 10-K.
Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.
Every filing on one line
Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.
All 38 events
- Oct 29, 2026 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Oct 29, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
- Sep 8, 2026 Planned sale Robert E. Hull (Executive VP & COO) gave notice of a planned sale of 21,000 shares worth about $402KForm 144, approximate sale date Sep 8, 2026
- Jul 31, 2026 Offering At-the-market program: up to $1.0B of common stock424B5 · from time to time through the sales agents.
- Jul 31, 2026 8-K Other events8-K item 8.01
- Jul 30, 2026 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Jul 30, 2026 10-Q Quarterly report (10-Q)period ended Jun 30, 2026
- Jun 22, 2026 Planned sale Amanda L Callaway (Officer) gave notice of a planned sale of 25,767 shares worth about $519KForm 144, approximate sale date Jun 23, 2026
- May 20, 2026 8-K Shareholder vote results8-K item 5.07
- May 19, 2026 8-K Material agreement signed, New debt or obligation8-K items 1.01, 2.03
- May 7, 2026 8-K Material agreement signed, New debt or obligation, Unregistered share sale8-K items 1.01, 2.03, 3.02
- May 5, 2026 8-K Other events8-K item 8.01
- May 1, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
- Apr 30, 2026 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Feb 27, 2026 8-K Regulation FD disclosure8-K item 7.01
- Feb 23, 2026 Auditor Auditor change8-K item 4.01
- Feb 13, 2026 10-K Annual report (10-K)period ended Dec 31, 2025
- Feb 12, 2026 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Jan 7, 2026 Officer CFO changeThe Board of Directors of Healthcare Realty Trust Incorporated (the “Company”) has appointed Daniel Gabbay to serve as the Company’s Executive Vice President and Chief Financial Officer effective January 12, 2026.
- Dec 17, 2025 Offering At-the-market program: up to $1.0B of common stock424B5 · from time to time through the sales agents.
- Dec 17, 2025 8-K Material agreement signed8-K item 1.01
- Oct 31, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
- Oct 30, 2025 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Aug 1, 2025 10-Q Quarterly report (10-Q)period ended Jun 30, 2025
- Jul 31, 2025 8-K Material agreement signed, New debt or obligation8-K items 1.01, 2.03
- Jul 31, 2025 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Jun 23, 2025 8-K Director or officer change, Regulation FD disclosure8-K items 5.02, 7.01
- May 22, 2025 8-K Director or officer change, Shareholder vote results8-K items 5.02, 5.07
- May 1, 2025 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- May 1, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
- Apr 7, 2025 8-K Director or officer change, Regulation FD disclosure8-K items 5.02, 7.01
- Feb 28, 2025 8-K Regulation FD disclosure8-K item 7.01
- Feb 19, 2025 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Feb 19, 2025 10-K Annual report (10-K)period ended Dec 31, 2024
- Jan 3, 2025 8-K Director or officer change (amended)8-K item 5.02
- Dec 9, 2024 8-K Director or officer change (amended)8-K item 5.02
- Dec 9, 2024 8-K Director or officer change, Regulation FD disclosure8-K items 5.02, 7.01
- Dec 9, 2024 8-K Material agreement signed, Director or officer change, Regulation FD disclosure8-K items 1.01, 5.02, 7.01
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind · each form links to sec.gov
| Filed | Form | What it is |
|---|---|---|
| Nov 13, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Oct 29, 2026 | 10-Q | Quarterly report |
| Oct 29, 2026 | 8-K | Quarterly results, Regulation FD disclosure |
| Sep 9, 2026 | 4 | Insider trade |
| Sep 8, 2026 | 144 | Notice of planned insider sale |
| Aug 11, 2026 | EFFECT | |
| Jul 31, 2026 | S-3 | |
| Jul 31, 2026 | 8-K | Other events |
| Jul 31, 2026 | 424B5 | Prospectus |
| Jul 31, 2026 | S-3ASR | Shelf registration |
| Jul 30, 2026 | 10-Q | Quarterly report |
| Jul 30, 2026 | 8-K | Quarterly results, Regulation FD disclosure |
| Jun 23, 2026 | 4 | Insider trade |
| Jun 22, 2026 | 144 | Notice of planned insider sale |
| May 20, 2026 | 4 | Insider trade |
| May 20, 2026 | 4 | Insider trade |
| May 20, 2026 | 4 | Insider trade |
| May 20, 2026 | 8-K | Shareholder vote results |
| May 20, 2026 | 4 | Insider trade |
| May 20, 2026 | 4 | Insider trade |
| May 19, 2026 | 8-K | Material agreement signed, New debt or obligation |
| May 7, 2026 | 8-K | Material agreement signed, New debt or obligation, Unregistered share sale |
| May 5, 2026 | 8-K | Other events |
| May 1, 2026 | 10-Q | Quarterly report |
| Apr 30, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Apr 30, 2026 | 8-K | Quarterly results, Regulation FD disclosure |
| Apr 29, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Apr 15, 2026 | 4 | Insider trade |
| Apr 7, 2026 | ARS | Annual report to shareholders |
| Apr 7, 2026 | DEFA14A | Extra proxy material |
| Apr 7, 2026 | DEF 14A | Proxy statement |
| Mar 27, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Mar 6, 2026 | 4 | Insider trade |
| Mar 5, 2026 | 4 | Insider trade |
| Feb 27, 2026 | 8-K | Regulation FD disclosure |
| Feb 25, 2026 | 4 | Insider trade |
| Feb 25, 2026 | 3 | New insider |
| Feb 23, 2026 | 8-K | Auditor change |
| Feb 17, 2026 | 4 | Insider trade |
| Feb 13, 2026 | 10-K | Annual report |
| Feb 12, 2026 | 8-K | Quarterly results, Regulation FD disclosure |
| Feb 11, 2026 | 4 | Insider trade |
| Feb 11, 2026 | 4 | Insider trade |
| Feb 11, 2026 | 4 | Insider trade |
| Feb 11, 2026 | 4 | Insider trade |
| Feb 11, 2026 | 4 | Insider trade |
| Jan 7, 2026 | 8-K | Director or officer change, Regulation FD disclosure |
| Jan 5, 2026 | 4 | Insider trade |
| Jan 5, 2026 | 4 | Insider trade |
| Jan 5, 2026 | 4 | Insider trade |
| Jan 5, 2026 | 4 | Insider trade |
| Jan 5, 2026 | 4 | Insider trade |
| Jan 5, 2026 | 4 | Insider trade |
| Jan 2, 2026 | 4 | Insider trade |
| Jan 2, 2026 | 4 | Insider trade |
| Dec 17, 2025 | 8-K | Material agreement signed |
| Dec 17, 2025 | 424B5 | Prospectus |
| Dec 15, 2025 | 4 | Insider trade |
| Dec 15, 2025 | 4 | Insider trade |
| Dec 15, 2025 | 4 | Insider trade |
| Dec 15, 2025 | 4 | Insider trade |
| Dec 8, 2025 | 4 | Insider trade |
| Nov 14, 2025 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Oct 31, 2025 | 10-Q | Quarterly report |
| Oct 30, 2025 | 8-K | Quarterly results, Regulation FD disclosure |
| Sep 25, 2025 | SCHEDULE 13D/A | 5%+ owner (active), amended |
| Sep 5, 2025 | 4 | Insider trade |
| Sep 4, 2025 | 144 | Notice of planned insider sale |
| Aug 13, 2025 | 4 | Insider trade |
| Aug 11, 2025 | 4 | Insider trade |
| Aug 1, 2025 | 10-Q | Quarterly report |
| Jul 31, 2025 | 8-K | Quarterly results, Regulation FD disclosure |
| Jul 31, 2025 | 8-K | Material agreement signed, New debt or obligation |
| Jun 23, 2025 | 8-K | Director or officer change, Regulation FD disclosure |
| May 22, 2025 | 4 | Insider trade |
| May 22, 2025 | 4 | Insider trade |
| May 22, 2025 | 4 | Insider trade |
| May 22, 2025 | 4 | Insider trade |
| May 22, 2025 | 4 | Insider trade |
| May 22, 2025 | 4 | Insider trade |
| May 22, 2025 | 4 | Insider trade |
| May 22, 2025 | 4 | Insider trade |
| May 22, 2025 | 4 | Insider trade |
| May 22, 2025 | 4 | Insider trade |
| May 22, 2025 | 4 | Insider trade |
| May 22, 2025 | 8-K | Director or officer change, Shareholder vote results |
| May 14, 2025 | 4 | Insider trade |
| May 1, 2025 | 8-K | Quarterly results, Regulation FD disclosure |
| May 1, 2025 | 10-Q | Quarterly report |
| Apr 17, 2025 | 4 | Insider trade |
| Apr 17, 2025 | 3 | New insider |
| Apr 16, 2025 | 4 | Insider trade |
| Apr 8, 2025 | ARS | Annual report to shareholders |
| Apr 8, 2025 | DEFA14A | Extra proxy material |
| Apr 8, 2025 | DEF 14A | Proxy statement |
| Apr 7, 2025 | 8-K | Director or officer change, Regulation FD disclosure |
| Mar 3, 2025 | 4 | Insider trade |
| Mar 3, 2025 | 4 | Insider trade |
| Mar 3, 2025 | 4 | Insider trade |
| Feb 28, 2025 | 8-K | Regulation FD disclosure |
Show the other 75 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.
Sources
SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.
Also
Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/HR/export.csv") into a cell.